These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22077443)

  • 1. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
    Kumano-Kuramochi M; Shimozu Y; Wakita C; Ohnishi-Kameyama M; Shibata T; Matsunaga S; Takano-Ishikawa Y; Watanabe J; Goto M; Xie Q; Komba S; Uchida K; Machida S
    Biochem J; 2012 Feb; 442(1):171-80. PubMed ID: 22077443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
    Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
    Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
    J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.
    Li L; Roumeliotis N; Sawamura T; Renier G
    Circ Res; 2004 Oct; 95(9):877-83. PubMed ID: 15472120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
    Chen M; Masaki T; Sawamura T
    Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
    J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS.
    Bao MH; Zhang YW; Lou XY; Xiao Y; Cheng Y; Zhou HH
    Can J Physiol Pharmacol; 2014 Apr; 92(4):299-306. PubMed ID: 24708212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein.
    Moriwaki H; Kume N; Sawamura T; Aoyama T; Hoshikawa H; Ochi H; Nishi E; Masaki T; Kita T
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1541-7. PubMed ID: 9763524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
    Chen X; Zhang T; Du G
    Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.
    Akhmedov A; Rozenberg I; Paneni F; Camici GG; Shi Y; Doerries C; Sledzinska A; Mocharla P; Breitenstein A; Lohmann C; Stein S; von Lukowicz T; Kurrer MO; Borén J; Becher B; Tanner FC; Landmesser U; Matter CM; Lüscher TF
    Eur Heart J; 2014 Oct; 35(40):2839-48. PubMed ID: 24419805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB; Anwar K; Wirkowski P
    Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
    Zhao W; Ma G; Chen X
    Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells.
    Li L; Renier G
    Atherosclerosis; 2009 May; 204(1):40-6. PubMed ID: 18801483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.
    Aoyama T; Fujiwara H; Masaki T; Sawamura T
    J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.
    Xu S; Liu Z; Huang Y; Le K; Tang F; Huang H; Ogura S; Little PJ; Shen X; Liu P
    Transl Res; 2012 Aug; 160(2):114-24. PubMed ID: 22677363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells.
    Oka K; Sawamura T; Kikuta K; Itokawa S; Kume N; Kita T; Masaki T
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9535-40. PubMed ID: 9689115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand.
    Shibata T; Shimozu Y; Wakita C; Shibata N; Kobayashi M; Machida S; Kato R; Itabe H; Zhu X; Sayre LM; Uchida K
    J Biol Chem; 2011 Jun; 286(22):19943-57. PubMed ID: 21471194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proatherogenic effects of 4-hydroxynonenal.
    Nègre-Salvayre A; Garoby-Salom S; Swiader A; Rouahi M; Pucelle M; Salvayre R
    Free Radic Biol Med; 2017 Oct; 111():127-139. PubMed ID: 28040472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
    Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.